Last reviewed · How we verify

NCT03749044

ASA Patterns for Prevention of Preeclampsia in SLE Pregnancies

Completed NA Last updated 13 March 2024
What this trial tests

NA trial testing Patient Educational Tool in Pre-Eclampsia in 73 participants. Completed in 11 March 2024.

Timeline
28 May 2018
Primary endpoint
11 March 2024
11 March 2024

Quick facts

Lead sponsorMcGill University Health Centre/Research Institute of the McGill University Health Centre
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposeother
Enrollment73
Start date28 May 2018
Primary completion11 March 2024
Estimated completion11 March 2024
Sites1 location across Canada

Drugs / interventions tested

Conditions studied

Sponsor

McGill University Health Centre/Research Institute of the McGill University Health Centre

Who can join

Adults 18 to 45, female only, with Pre-Eclampsia or Pregnancy Complications. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Preeclampsia is a serious maternal condition affecting up to 5% of pregnancies from the general population and up to 30% of lupus pregnancies. Aspirin (acetylsalicylic acid- ASA) has been shown to reduce the risk of preeclampsia, by half, in women at high risk. Therefore, it is recommended that health professionals initiate aspirin early during pregnancy in women with lupus. Despite this recommendation, there are currently no studies of aspirin in women with lupus for this indication. This is a critical knowledge gap as aspirin could potentially have a large benefit in this high-risk population. The investigator will perform a RCT to evaluate the effect of a specifically designed patient educational tool on preeclampsia knowledge and ASA adherence in pregnant women with SLE. The research efforts will improve reproductive health of SLE women and the outcomes of offsprings.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. An educational tool to improve PREeclamPsia knowledge and Aspirin adheRence in lupus prEgnancies: the PREPARE trial.
    Lee JE, Mendel A, Malhamé I, Barber MRW, et al · · 2025 · cited 2× · PMID 40578323 · DOI 10.1093/rheumatology/keaf334

Verify or expand the search:

Other recruiting trials for Pre-Eclampsia

Currently open trials in the same condition.

Other McGill University Health Centre/Research Institute of the McGill University Health Centre trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03749044.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing